Q2
Nobel Biocare’s Q2 profits double as it fields buyout interest
ConvaTec said to explore 2015 sale
Medtronic’s Q1 earnings beat The Street on modest sales bump
Diabetes: DexCom’s revenues jump 64% in Q2
EnteroMedics’ losses widen as it chases FDA approval

Minnesota-based EnteroMedics (NSDQ:ETRM) gained modestly this week after announcing its latest financial report, even though the company missed the mark by a penny.
Strong Q4, $750M buyback give CareFusion a boost

CareFusion (NYSE:CFN) posted a stellar 4th-quarter, posting double-digit growth in revenues and earnings and beating Wall Street’s estimates.
Masimo sinks as Q2 misses the mark
Baxano: Strong Q2, new patents can’t appease Wall Street

Baxano Surgical (NSDQ:BAXS) just can’t seem to do right by Wall Street.